Sanofi
SNY
SNY
478 hedge funds and large institutions have $7.6B invested in Sanofi in 2018 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 133 increasing their positions, 181 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
1.8% less ownership
Funds ownership: 16.96% → 15.16% (-1.8%)
11% less capital invested
Capital invested by funds: $8.53B → $7.6B (-$930M)
27% less repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 181
Holders
478
Holding in Top 10
10
Calls
$51.2M
Puts
$11.5M
Top Buyers
| 1 | +$22M | |
| 2 | +$14.7M | |
| 3 | +$11.8M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$9.92M |
| 5 |
Barclays
London,
United Kingdom
|
+$8.19M |
Top Sellers
| 1 | -$724M | |
| 2 | -$86.1M | |
| 3 | -$63.2M | |
| 4 |
Morgan Stanley
New York
|
-$51.5M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$17.4M |